Drugs / PF-06282999
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01965600 | Mar 2014 → Feb 2015 | — | Pfizer | Terminated | No outcome recorded |
| Phase 1 | NCT01707082 | Oct 2012 → May 2013 | — | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT01626976 | Jun 2012 → Mar 2013 | — | Pfizer | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-06282999 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01626976 ↗ |
| Modality | Small molecule | — CHEMBL3633460 ↗ |
| Route | Oral | “PF-06282999 Administered Orally” NCT01626976 ↗ |